March 17, 2018 6:42 PM ET

Healthcare Equipment and Supplies

Company Overview of Zipline Medical, Inc.

Company Overview

Zipline Medical, Inc. develops and markets non-invasive skin closure solutions. The company’s product, Zip Surgical Skin Closure, is used for application in various medical specialties, including electrophysiology, cardiology, orthopedics, dermatology, emergency medicine, plastic reconstructive surgery, OB/GYN, and general surgery. Zipline Medical, Inc. was founded in 2009 and is based in Campbell, California.

747 Camden Avenue

Suite A

Campbell, CA 95008

United States

Founded in 2009





Key Executives for Zipline Medical, Inc.

CEO, President & Director
Age: 56
Founder & Director
CFO & VP of Finance
Vice President of Operations
Director of Research & Development
Compensation as of Fiscal Year 2017.

Zipline Medical, Inc. Key Developments

ZipLine Medical, Inc. Announces Results from an Economic Study

ZipLine Medical, Inc. announced results from an economic study that showed that Zip Surgical Skin Closure reduced post-discharge costs for total knee arthroplasty (TKA) when compared to staples. Results were presented at the Knee Society Members Meeting by Roger Emerson, MD, of the Texas Center for Joint Replacement, Plano, Texas. The study encompassed 130 consecutive TKA patients, with half of subjects closed with staples and half closed with Zip Surgical Skin Closure. All surgeries were performed at the Texas Center for Joint Replacement by the same surgeon using the same approach and implant, and were closed by the same surgical physician’s assistant. Patients were followed from surgery to first clinic post-operative visit (day 21-28) for assessment. The study findings showed that the Zip reduced all of the following measures when compared to staples: 46% reduction in incision-related actual clinic costs; 60% reduction in incision-related phone calls; 60% reduction in incision-related clinic visits; and 75% reduction in incision-related antibiotics prescribed. In addition, patients found the resulting scar from the Zip to be cosmetically more appealing, and the Zip device less painful to remove, than staples.

ZipLine Medical, Inc. Receives China Food and Drug Administration Approval for Non-Invasive Zip Skin Closure System

ZipLine Medical, Inc. announced China Food and Drug Administration (CFDA) approval and commercial availability of its Zip® Surgical Skin Closure device in the region. This clearance will give the company access to the $543 million Chinese wound closure device market serving over 40 million procedures, including growing specialties where the Zip has shown significant benefit, such as orthopedics for total joint replacement and obstetrics for Cesarean-section and hysterectomy procedures. The Zip is a non-invasive, efficient and easy-to-use wound closure device that replaces traditional sutures, staples and glue for surgical incisions and lacerations. It results in a comfortable, secure wound and the device’s unique force distribution system results in high patient comfort and excellent scar quality. The Zip’s micro-adjustability and reversibility provide surgeons with precise control and flexibility during closure. Because application and removal are simple, clinicians can delegate the closure task and, at the clinician’s discretion, patients may remove the Zip at home. Unlike staples or sutures, there are no skin punctures with the Zip, so scarring is minimal and there are no added pathways for bacteria to enter. The Zip’s benefits have been demonstrated in clinical studies in orthopedic total-joint arthroplasty, cardiothoracic surgery, electrophysiology and dermatology.

ZipLine Medical Inc. Announces Publication of Positive Results from the First Prospective, Randomized, Controlled Study of Its Zip Surgical Skin Closure in Pediatric Surgery

ZipLine Medical Inc. announced publication of positive results from the first prospective, randomized, controlled study of its Zip® Surgical Skin Closure in pediatric surgery. In the study, the Zip demonstrated significant improvements in scar appearance, efficiency and patient pain compared to suturing. Results were published online in the Annals of Thoracic Surgery. The study of 214 pediatric patients undergoing cardiovascular surgery compared the Zip to continuous subcuticular polypropylene sutures for skin closure at three months. The study found: Significant improvement in scar appearance with the Zip, as evaluated by two plastic surgeons using the Vancouver Scar Scale (VSS) (p). Three times shorter skin closure time with the Zip (113.0 ± 9.1 seconds versus 375.9 ± 60.2 seconds). Significantly fewer patients cried or complained during removal of the Zip (7.1% versus 52.5%,).

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
206 Ortho, Inc. United States
21st Century Scientific, Inc. United States

Recent Private Companies Transactions

Private Placement
June 6, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Zipline Medical, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at